EUVIMEDEUVIMED entdecken
Crossref

The Potential Dual Roles of Metallothionein‐1/‐2 in Diabetic Osteoarthritis

Yu-Ping Su, Rong-Ze Hsieh, Kuo-Ti Peng, Chung-Sheng Shi iD, Kuo-Chin Huang, Shun-Fu Chang iD

Journal of Cellular Physiology · 2025

DOI: 10.1002/jcp.70056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Yu-Ping Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Traumatology, Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Osteoarthritis, Metallothionein, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: The funders provided funding to support personnel and laboratory supplies but did not play a role in the study design, data collection, data interpretation, or….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is increasingly recognized as a chronic inflammatory degenerative joint disease. Recent evidence exhibits a higher prevalence of OA among patients with type II diabetes mellitus (T2DM). Metallothioneins (MTs) are important proteins involved in controlling physiology and pathophysiology. MT‐1/MT‐2 have been further found their positive correlation with OA progression, but their precise roles need more examination. This study aimed to investigate the role of MT‐1/MT‐2 in the development of diabetic OA and the underlying mechanisms. Cartilage was collected from patients with OA‐only and T2DM‐OA, and from rats classified as healthy, T2DM, and T2DM with destabilization of medial meniscus (DMM) surgery. Additionally, a cell model treated with high glucose (HG) or advanced glycation end products (AGEs) was used to investigate underlying mechanisms. Our results revealed that MT‐1/MT‐2 levels were elevated in cartilage from T2DM‐OA patients and rats, as well as in T2DM rats subjected to DMM surgery. Similarly, primary chondrocytes treated with HG and AGE showed increased expression of MT‐1/MT‐2, with distinct distributions and regulatory mechanisms: (a) MT‐1 enhanced MMP and transcription factor activity without affecting their expressions, whereas MT‐2 increased both the activity and expression of MMPs and transcription factors; (b) MT‐1 reduced IL6/IL8 expression, while MT‐2 promoted it. Furthermore, this differential regulation appears to be mediated by BMP2 autocrine stimulation. These findings underscore the dual role of MT‐1/MT‐2 in simultaneously activating self‐repair and degenerative processes, potentially influencing diabetic cartilage pathogenesis. Our study suggests that MT‐1/MT‐2 may serve as valuable theranostic targets for diabetic OA in future clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisMetallothioneinDiabetes Mellitus, Type 2AnimalsHumansChondrocytesMaleRatsGlycation End Products, AdvancedMiddle AgedRats, Sprague-DawleyFemaleGlucoseCartilage, ArticularAged

Stichwörter der Autor:innen

advanced glycation end productsbone morphogenetic protein 2diabetes mellitusmetallothioneinsosteoarthritis

Substanzen

MetallothioneinGlycation End Products, AdvancedGlucoseMT2A protein, humanMt2A protein, ratMT1A protein, human

Autor:innen und Institutionen

  • Department of Orthopaedics and Traumatology, Veterans General Hospital, Taipei, Taiwan.
  • Department of Surgery, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Medical Research and Development, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
  • Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of Orthopaedics, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
  • College of Medicine, Chang Gung University, Taoyuan, Taiwan.

ORCID-Profile: Chung-Sheng Shi, Shun-Fu Chang

Förderung

  • The funders provided funding to support personnel and laboratory supplies but did not play a role in the study design, data collection, data interpretation, or…

Zitieren

APA

Su, Y. P., Hsieh, R. Z., Peng, K. T., Shi, C. S., Huang, K. C., & Chang, S. F. (2025). The Potential Dual Roles of Metallothionein‐1/‐2 in Diabetic Osteoarthritis. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70056

Vancouver

Su YP, Hsieh RZ, Peng KT, Shi CS, Huang KC, Chang SF. The Potential Dual Roles of Metallothionein‐1/‐2 in Diabetic Osteoarthritis. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70056

BibTeX
@article{Su2025,
  author = {Su, Yu-Ping and Hsieh, Rong-Ze and Peng, Kuo-Ti and Shi, Chung-Sheng and Huang, Kuo-Chin and Chang, Shun-Fu},
  title = {The Potential Dual Roles of Metallothionein‐1/‐2 in Diabetic Osteoarthritis},
  journal = {Journal of Cellular Physiology},
  year = {2025},
  doi = {10.1002/jcp.70056}
}
Kostenlos starten →